Physician

James Frederick Guenther, D.O.

According to 2025 Medicare claims, James Guenther, D.O. (NPI: 1417933490) practices addiction medicine in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is BRIGHTVIEW, LLC (NPI: 1659769446; TIN: 472519577) and primary practice location at 45458-2141. Guenther is affiliated with the Health Centers of Ohio ACO LLC (ACO ID: A5411), participating under the MSSP model.

Guenther's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 15 traditional Medicare patients, billed 58 HCPCS/CPT codes, and received $5,525 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 80 prescription claims across 42 beneficiaries totaling $3,788 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). Open Payments data shows 1 records totaling $29. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $42,952 to $5,525. Similarly, Part D prescription costs have declined steadily, from $42,840 to $3,788. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$42K$85K2015 Medicare payment: $42,952 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $40,789 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $67,248 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $84,697 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $34,014 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $11,702 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $25,950 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $14,129 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $19,417 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,525 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015127870$42,952
2016130607$40,789
2017611,006$67,248
2018391,391$84,697
201982554$34,014
202053139$11,702
202169314$25,950
202262172$14,129
202362267$19,417
20241558$5,525

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$36K$71K2015 Drug cost: $42,840 (USD; Tot_Drug_Cst)2016 Drug cost: $46,964 (USD; Tot_Drug_Cst)2017 Drug cost: $59,228 (USD; Tot_Drug_Cst)2018 Drug cost: $71,338 (USD; Tot_Drug_Cst)2019 Drug cost: $42,488 (USD; Tot_Drug_Cst)2020 Drug cost: $22,619 (USD; Tot_Drug_Cst)2021 Drug cost: $32,926 (USD; Tot_Drug_Cst)2022 Drug cost: $15,230 (USD; Tot_Drug_Cst)2023 Drug cost: $18,919 (USD; Tot_Drug_Cst)2024 Drug cost: $3,788 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015117464$42,840
2016113475$46,964
201784480$59,228
201850656$71,338
201995469$42,488
2020103262$22,619
2021115265$32,926
202299189$15,230
202380166$18,919
20244280$3,788

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1221$63

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl21387$2,193
Naloxone HclNaloxone Hcl15235$702

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$29Braeburn Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Frederick Guenther, D.O.?

Tedicare shows public-source Medicare data for James Frederick Guenther, D.O. (NPI 1417933490), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Frederick Guenther, D.O. have ACO affiliation data?

James Frederick Guenther, D.O. is shown with ACO affiliation data for Health Centers of Ohio ACO LLC (MSSP, ACO ID A5411).

What billing organization is linked to James Frederick Guenther, D.O.?

James Frederick Guenther, D.O. is linked to BRIGHTVIEW, LLC (billing NPI 1659769446) in the available physician profile data.

Does James Frederick Guenther, D.O. have Open Payments data?

James Frederick Guenther, D.O. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.